Biocryst researchers convicted

Former VP-Clinical Development Harry Snyder and his wife Renee Peugeot convicted March 23 by Birmingham, Ala. federal jury for falsifying test results on Biocryst's BCX-34, a drug which had been developed for psoriasis and T-cell lymphoma. The defendants were convicted on five counts, including making false statements to FDA in the statistical analysis on a Form 1571 regarding the effectiveness of BCX-34 and perpetrating mail fraud. Sentencing is scheduled for June 15. The maximum sentence is five years for each count. The U.S. attorney's office indicated it will not seek charges against the company. Biocryst discontinued development of BCX-34 in the fall of 1997